Campbell & Co Investment Adviser’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-41,339
Closed -$2.16M 1354
2026
Q1
$2.16M Sell
41,339
-22,659
-35% -$1.36M 0.12% 250
2025
Q4
$3.76M Buy
63,998
+59,694
+1,387% +$3.63M 0.18% 161
2025
Q3
$239K Sell
4,304
-30,867
-88% -$1.65M 0.02% 971
2025
Q2
$1.81M Buy
35,171
+24,416
+227% +$1.23M 0.11% 275
2025
Q1
$631K Buy
+10,755
New +$729K 0.05% 590
2024
Q3
Sell
-61,133
Closed -$4.38M 1326
2024
Q2
$4.38M Buy
61,133
+46,074
+306% +$3.39M 0.37% 34
2024
Q1
$1.06M Buy
+15,059
New +$1.08M 0.09% 373
2023
Q4
Sell
-11,516
Closed -$784K 1335
2023
Q3
$784K Buy
11,516
+6,772
+143% +$535K 0.09% 357
2023
Q2
$387K Sell
4,744
-4,287
-47% -$345K 0.07% 553
2023
Q1
$670K Sell
9,031
-2,149
-19% -$166K 0.12% 304
2022
Q4
$927K Sell
11,180
-8,644
-44% -$686K 0.22% 114
2022
Q3
$1.41M Buy
19,824
+11,204
+130% +$968K 0.32% 56
2022
Q2
$747K Buy
+8,620
New +$808K 0.2% 148
2022
Q1
Sell
-2,724
Closed -$352K 898
2021
Q4
$352K Sell
2,724
-1,600
-37% -$196K 0.12% 299
2021
Q3
$524K Buy
4,324
+1,200
+38% +$146K 0.17% 201
2021
Q2
$352K Buy
+3,124
New +$329K 0.15% 263
2020
Q4
Sell
-4,724
Closed -$293K 564
2020
Q3
$293K Buy
+4,724
New +$307K 0.22% 188
2020
Q1
Sell
-10,236
Closed -$562K 472
2019
Q4
$562K Buy
+10,236
New +$537K 0.17% 198
2019
Q3
Sell
-4,312
Closed -$225K 767
2019
Q2
$225K Buy
+4,312
New +$217K 0.1% 420
2019
Q1
Sell
-7,472
Closed -$299K 612
2018
Q4
$299K Buy
+7,472
New +$312K 0.29% 158

Other funds holding TECH

Campbell & Co Investment Adviser's TECH Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 41,339 shares — an estimated $2.16M sold.

Campbell & Co Investment Adviser first reported a position in TECH in Q4 2018 and held it in 20 quarters. The position peaked at $4.38M in Q2 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 41,339 Bio-Techne shares in Q2 2026, an estimated $2.16M.
  • Campbell & Co Investment Adviser first reported a position in Bio-Techne in Q4 2018 and held it in 20 quarters.
  • Campbell & Co Investment Adviser's Bio-Techne position peaked at $4.38M in Q2 2024.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.